SightfileU.S. market data from official filings

INTEGER HLDGS CORP (ITGR)

Name: INTEGER HLDGS CORP (ITGR) — Institutional ownership, SEC filings and insider activity
Creator: Sightfile
License: https://www.sec.gov/privacy#dissemination

Institutional ownership, SEC filings and insider activity

Sector: Healthcare & Pharma · SEC CIK 0001114483 · EDGAR filings · Updated 2026-07-10

INTEGER HLDGS CORP (ITGR) has reported institutional ownership of 115.3%, with 318 institutional managers holding positions valued at $3.43B per the latest 13F reporting period.

Institutional ownership

115.3%

Institutional managers

318

Reported 13F value

$3.43B

Insider activity

96 trans.

−$44.2M net selling

Latest updates

2026-07-10 — Initial insider ownership filed (Form 3)
2026-07-10 — Insider transaction reported (Form 4)
2026-07-01 — Insider transaction reported (Form 4)
2026-07-01 — Insider transaction reported (Form 4)
2026-06-26 — Current report (8-K) filed
2026-05-22 — Insider transaction reported (Form 4)

Institutional ownership overview

According to SEC 13F filings tracked by Sightfile, INTEGER HLDGS CORP has 318 institutional holders and institutional ownership of 115.3%.

Insider activity

Insiders reported 96 transactions (4 buys, 11 sells) across 22 reporting insiders, with a net reported value of −$44.2M.

Related companies

TWIST BIOSCIENCE CORP (TWST) · TRANSMEDICS GROUP INC (TMDX) · TG THERAPEUTICS INC (TGTX) · DYNE THERAPEUTICS INC (DYN) · STRUCTURE THERAPEUTICS INC (GPCR) · CORCEPT THERAPEUTICS INC (CORT)

See full history, cross-references and alerts on Sightfile

Sightfile provides information only — not investment advice, recommendations, or an assessment of any security. Data is derived from official public sources (SEC EDGAR and U.S. government agencies), may contain errors or delays, and should be verified against the source filing before relying on it.
Data sources: SEC EDGAR (filings, 13F, FTD), aggregated by Sightfile. Page updated 2026-07-10.